C69.32
C69.32 — Malignant neoplasm of left choroid
Billable / specific codeICD-10-CMleft
C69.32 is a billable, specific ICD-10-CM code for malignant neoplasm of left choroid. It is valid for submission on a claim.
Risk adjustment
C69.32 risk-adjusts. Under the CMS-HCC V28 model it maps to this category:
- HCC 23 Prostate, Breast, and Other Cancers and Tumors0.186 RAF
Coefficient shown for the Community Non-dual Aged segment. A higher HCC in the same hierarchy will suppress this one, so capturing it does not always add score.
Medicare coverage
C69.32 is named in 83 Medicare coverage policies — 83 listing it as supporting medical necessity. Which of them applies to you depends on your Medicare contractor, and coverage genuinely differs by state.
- A52450Billing and Coding: Paclitaxel (e.g., Taxol®/Abraxane ™)
- A52450Billing and Coding: Paclitaxel (e.g., Taxol®/Abraxane ™)
- A52480Oral Antiemetic Drugs (Replacement for Intravenous Antiemetics) - Policy Article
- A52986Billing and Coding: Biomarkers for Oncology
Related codes at this level
Codes that share C69.3. If C69.32 is not quite right, the correct code is usually one of these.
Questions about C69.32
- Is C69.32 a billable ICD-10-CM code?
- Yes. C69.32 is a billable, specific ICD-10-CM code and is valid for submission on a claim.
- Where does C69.32 sit in the tabular list?
- Neoplasms (C00-D49), in the block Malignant neoplasms of eye, brain and other parts of central nervous system (C69-C72).